LDLR Antikörper (C-Term)
Kurzübersicht für LDLR Antikörper (C-Term) (ABIN2781810)
Target
Alle LDLR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Sequenz
- VDSKLHSISS IDVNGGNRKT ILEDEKRLAH PFSLAVFEDK VFWTDIINEA
-
Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 86%, Horse: 93%, Human: 100%, Mouse: 100%, Pig: 100%, Rabbit: 100%, Rat: 93%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against LDLR. It was validated on Western Blot.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the C-terminal region of Human LDLR
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- LDLR (Low Density Lipoprotein Receptor (LDLR))
-
Andere Bezeichnung
- LDLR
-
Hintergrund
-
The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.
Alias Symbols: FH, FHC, LDLCQ2
Protein Interaction Partner: PCSK9, UBC, env, MAP4, PDIA3, CREBBP, PDIA4, HSP90B1, HSPA5, CANX, MYLIP, AP1M2, LDLR, SNX17, LDLRAP1, DAB1, PF4, APOE, APOB, LRPAP1, DAB2, CD36,
Protein Size: 682 -
Molekulargewicht
- 75 kDa
-
Gen-ID
- 3949
-
NCBI Accession
- NM_001195803, NP_001182732
-
Pathways
- Hepatitis C, Lipid Metabolism
Target
-